Moderna’s coronavirus vaccine shows promise in early results
The biotech company Moderna announced Monday (May 18) that their experimental coronavirus vaccine showed promising results in an early trial, known as a phase I study. After receiving a single dose of the vaccine, called mRNA-1273, all 45 of the…